{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:33:44Z","timestamp":1791974024201,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11864-021-00820-9","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:54:36Z","timestamp":1612932876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Postoperative Management of Salivary Gland Tumors"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4821-9090","authenticated-orcid":false,"given":"Nikhil P.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Broughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"issue":"6","key":"820_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.humpath.2017.05.014","volume":"66","author":"AK El-Naggar","year":"2017","unstructured":"El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017;66:10\u20132.","journal-title":"Hum Pathol"},{"issue":"3","key":"820_CR3","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1177\/014556131709600319","volume":"96","author":"AG Del Signore","year":"2017","unstructured":"Del Signore AG, Megwalu UC. The rising incidence of major salivary gland cancer in the United States. Ear, nose, & throat journal. 2017;96(3):E13\u2013e6.","journal-title":"Ear, nose, & throat journal"},{"issue":"2","key":"820_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74(2):134\u201348.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"820_CR5","first-page":"671","volume":"12","author":"RH Spiro","year":"1998","unstructured":"Spiro RH. Management of malignant tumors of the salivary glands. Oncology (Williston Park, NY). 1998;12(5):671\u201380 discussion 83.","journal-title":"Oncology (Williston Park, NY)"},{"issue":"1","key":"820_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","volume":"11","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Stenman G. Update from the 4th Edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head and neck pathology. 2017;11(1):55\u201367.","journal-title":"Head and neck pathology"},{"issue":"5","key":"820_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jamaoto.2015.3930","volume":"142","author":"MR Gilbert","year":"2016","unstructured":"Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, et al. A 20-year review of 75 cases of salivary duct carcinoma. JAMA otolaryngology-- head & neck surgery. 2016;142(5):489\u201395.","journal-title":"JAMA otolaryngology-- head & neck surgery"},{"key":"820_CR8","volume-title":"8th ed: springer","author":"AJCC Cancer Staging Manual","year":"2017","unstructured":"AJCC Cancer Staging Manual, Eighth Edition. 8th ed: springer; 2017."},{"issue":"1","key":"820_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","volume":"61","author":"CH Terhaard","year":"2005","unstructured":"Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61(1):103\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"820_CR10","first-page":"1135","volume":"276","author":"JK Ferrell","year":"2019","unstructured":"Ferrell JK, Mace JC, Clayburgh D. Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2019;276(4):1135\u201346.","journal-title":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery"},{"issue":"S2","key":"820_CR11","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1017\/S0022215116000566","volume":"130","author":"S Sood","year":"2016","unstructured":"Sood S, McGurk M, Vaz F. Management of salivary gland tumours: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S142\u2013s9.","journal-title":"J Laryngol Otol"},{"issue":"3","key":"820_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.coms.2017.03.008","volume":"29","author":"RA Ord","year":"2017","unstructured":"Ord RA, Ghazali N. Margin analysis: malignant salivary gland neoplasms of the head and neck. Oral and maxillofacial surgery clinics of North America. 2017;29(3):315\u201324.","journal-title":"Oral and maxillofacial surgery clinics of North America"},{"issue":"8","key":"820_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bjoms.2019.07.021","volume":"57","author":"M Garg","year":"2019","unstructured":"Garg M, Tudor-Green B, Bisase B. Current thinking in the management of adenoid cystic carcinoma of the head and neck. Br J Oral Maxillofac Surg. 2019;57(8):716\u201321.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"820_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/hed.23332","volume":"36","author":"T Ettl","year":"2014","unstructured":"Ettl T, Gosau M, Brockhoff G, Schwarz-Furlan S, Agaimy A, Reichert TE, et al. Predictors of cervical lymph node metastasis in salivary gland cancer. Head & neck. 2014;36(4):517\u201323.","journal-title":"Head & neck."},{"issue":"3","key":"820_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.amjoto.2012.11.012","volume":"34","author":"MP Herman","year":"2013","unstructured":"Herman MP, Werning JW, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM. Elective neck management for high-grade salivary gland carcinoma. Am J Otolaryngol. 2013;34(3):205\u20138.","journal-title":"Am J Otolaryngol"},{"key":"820_CR16","unstructured":"RTOG-1008: Radiation therapy with or without chemotherapy in treating patients with high-risk malignant salivary gland tumors that have been removed by surgery. ."},{"issue":"5","key":"820_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","volume":"103","author":"RL Bakst","year":"2019","unstructured":"\u2022\u2022 Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS. Perineural invasion and Perineural tumor spread in head and neck cancer. International journal of radiation oncology, biology, physics. 2019;103(5):1109\u201324 Important guideline discussing delineation of involved nerve pathways for neurotropic cancers of the head and neck.","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"820_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.oraloncology.2015.11.023","volume":"54","author":"A Hosni","year":"2016","unstructured":"Hosni A, Huang SH, Goldstein D, Xu W, Chan B, Hansen A, et al. Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy. Oral Oncol. 2016;54:75\u201380.","journal-title":"Oral Oncol"},{"issue":"7","key":"820_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/hed.24984","volume":"40","author":"S Cheraghlou","year":"2018","unstructured":"Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, et al. Adjuvant therapy in major salivary gland cancers: analysis of 8580 patients in the National Cancer Database. Head & neck. 2018;40(7):1343\u201355.","journal-title":"Head & neck"},{"issue":"6","key":"820_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0194599819827851","volume":"160","author":"K Aro","year":"2019","unstructured":"Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Yoshida EJ, et al. Survival impact of adjuvant therapy in salivary gland cancers following resection and neck dissection. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019;160(6):1048\u201357.","journal-title":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery"},{"issue":"6","key":"820_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/0194599817717661","volume":"157","author":"J Safdieh","year":"2017","unstructured":"Safdieh J, Givi B, Osborn V, Lederman A, Schwartz D, Schreiber D. Impact of adjuvant radiotherapy for malignant salivary gland tumors. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017;157(6):988\u201394.","journal-title":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery"},{"issue":"1","key":"820_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s12885-018-4578-0","volume":"18","author":"JY Jang","year":"2018","unstructured":"Jang JY, Choi N, Ko YH, Chung MK, Son YI, Baek CH, et al. Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer. BMC Cancer. 2018;18(1):672.","journal-title":"BMC Cancer"},{"issue":"12","key":"820_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1288\/00005537-199412000-00011","volume":"104","author":"H Laccourreye","year":"1994","unstructured":"Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, M\u00e9nard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope. 1994;104(12):1487\u201394.","journal-title":"Laryngoscope"},{"key":"820_CR24","doi-asserted-by":"crossref","unstructured":"Myssiorek D, Ruah CB, Hybels RL. Recurrent pleomorphic adenomas of the parotid gland. Head &amp; neck. 1990;12(4):332\u20136.","DOI":"10.1002\/hed.2880120410"},{"key":"820_CR25","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Witt RL, Eisele DW, Morton RP, Nicolai P, Poorten VV, Zb\u00e4ren P. Etiology and management of recurrent parotid pleomorphic adenoma. The laryngoscope. 2015;125(4):888\u201393 A comprehensive review of pleomorphic adenoma management.","DOI":"10.1002\/lary.24964"},{"issue":"1","key":"820_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjoto.2012.08.002","volume":"34","author":"AS Wallace","year":"2013","unstructured":"Wallace AS, Morris CG, Kirwan JM, Werning JW, Mendenhall WM. Radiotherapy for pleomorphic adenoma. Am J Otolaryngol. 2013;34(1):36\u201340.","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"820_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/1097-0142(197207)30:1<276::AID-CNCR2820300138>3.0.CO;2-V","volume":"30","author":"SO Krolls","year":"1972","unstructured":"Krolls SO, Boyers RC. Mixed tumors of salivary glands. Long-term follow-up. Cancer. 1972;30(1):276\u201381.","journal-title":"Cancer"},{"issue":"2","key":"820_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.amjsurg.2004.11.008","volume":"189","author":"P Zb\u00e4ren","year":"2005","unstructured":"Zb\u00e4ren P, Tschumi I, Nuyens M, Stauffer E. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg. 2005;189(2):203\u20137.","journal-title":"Am J Surg"},{"issue":"2","key":"820_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/000348949510400203","volume":"104","author":"PP Phillips","year":"1995","unstructured":"Phillips PP, Olsen KD. Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. The Annals of otology, rhinology, and laryngology. 1995;104(2):100\u20134.","journal-title":"The Annals of otology, rhinology, and laryngology"},{"key":"820_CR30","doi-asserted-by":"crossref","unstructured":"\u2022 Kligerman MP, Jin M, Ayoub N, Megwalu UC. Comparison of Parotidectomy with observation for treatment of pleomorphic adenoma in adults. JAMA otolaryngology-- head & neck surgery. 2020; Interesting modeling study of observation for pleomorphic adenoma.","DOI":"10.1001\/jamaoto.2020.2944"},{"issue":"2","key":"820_CR31","doi-asserted-by":"publisher","first-page":"E369","DOI":"10.1016\/j.ijrobp.2017.06.1483","volume":"99","author":"SJ Sandy","year":"2017","unstructured":"Sandy SJ, Suppiah S, Robbins JR. Role of adjuvant radiotherapy for resected salivary ductal carcinoma. International journal of radiation oncology, biology, physics. 2017;99(2):E369.","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"6","key":"820_CR32","first-page":"3045","volume":"37","author":"S Jang","year":"2017","unstructured":"Jang S, Patel PN, Kimple RJ, McCulloch TM. Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck. Anticancer Res. 2017;37(6):3045\u201352.","journal-title":"Anticancer Res"},{"issue":"10","key":"820_CR33","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/lary.26565","volume":"127","author":"S Ali","year":"2017","unstructured":"Ali S, Palmer FL, Katabi N, Lee N, Shah JP, Patel SG, et al. Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation. Laryngoscope. 2017;127(10):2265\u20139.","journal-title":"Laryngoscope"},{"key":"820_CR34","doi-asserted-by":"crossref","unstructured":"Lee A, Givi B, Osborn VW, Schwartz D, Schreiber D. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma. The Laryngoscope. 2017.","DOI":"10.1002\/lary.26516"},{"issue":"6","key":"820_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1749-4486.2009.02036.x","volume":"34","author":"AM Chen","year":"2009","unstructured":"Chen AM, Garcia J, Granchi P, Bucci MK, Lee NY. Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2009;34(6):539\u201345.","journal-title":"Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery"},{"issue":"19","key":"820_CR36","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/cncr.32208","volume":"125","author":"AJ Hay","year":"2019","unstructured":"Hay AJ, Migliacci J, Karassawa Zanoni D, McGill M, Patel S, Ganly I. Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: incidence and outcomes by site and histological type. Cancer. 2019;125(19):3354\u201366.","journal-title":"Cancer."},{"issue":"1","key":"820_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamaoto.2015.2805","volume":"142","author":"HM Baddour Jr","year":"2016","unstructured":"\u2022 Baddour HM Jr, Fedewa SA, Chen AY. Five- and 10-year cause-specific survival rates in carcinoma of the minor salivary gland. JAMA otolaryngology-- head & neck surgery. 2016;142(1):67\u201373 Long-term outcomes for minor salivary gland cancers.","journal-title":"JAMA otolaryngology-- head & neck surgery"},{"key":"820_CR38","doi-asserted-by":"crossref","unstructured":"Salgado LR, Spratt DE, Riaz N, Romesser PB, Wolden S, Rao S, et al. Radiation therapy in the treatment of minor salivary gland tumors. Am J Clin Oncol. 2014;37(5):492\u20137.","DOI":"10.1097\/COC.0b013e31827e54e5"},{"issue":"1","key":"820_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-011-0174-0","volume":"13","author":"MB Gillespie","year":"2012","unstructured":"Gillespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options in Oncol. 2012;13(1):58\u201370.","journal-title":"Curr Treat Options in Oncol"},{"key":"820_CR40","doi-asserted-by":"crossref","unstructured":"Pederson AW, Haraf DJ, Blair EA, Stenson KM, Witt ME, Vokes EE, Salama JK Chemoreirradiation for recurrent salivary gland malignancies. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2010;95(3):308\u2013311.","DOI":"10.1016\/j.radonc.2010.03.006"},{"key":"820_CR41","doi-asserted-by":"crossref","unstructured":"Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, M\u00fcnter MW, Herfarth KK, Debus J Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2015;114(2):182\u2013188.","DOI":"10.1016\/j.radonc.2015.01.002"},{"key":"820_CR42","doi-asserted-by":"crossref","unstructured":"Vischioni B, Dhanireddy B, Severo C, Bonora M, Ronchi S, Vitolo V, Fiore MR, D'Ippolito E, Petrucci R, Barcellini A, Ciurlia E, Iannalfi A, Hasegawa A, Molinelli S, Mirandola A, Valvo F, Orecchia R Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2020;145:172\u2013177.","DOI":"10.1016\/j.radonc.2020.01.004"},{"issue":"2","key":"820_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13566-012-0010-6","volume":"1","author":"SD Karam","year":"2012","unstructured":"Karam SD, Snider JW, Wang H, Wooster M, Lominska C, Deeken J, et al. Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy. Journal of radiation oncology. 2012;1(2):147\u201353.","journal-title":"Journal of radiation oncology"},{"issue":"11","key":"820_CR44","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","volume":"142","author":"A Amini","year":"2016","unstructured":"Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, et al. Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the National Cancer Data Base. JAMA otolaryngology-- head & neck surgery. 2016;142(11):1100\u201310.","journal-title":"JAMA otolaryngology-- head & neck surgery."},{"issue":"9","key":"820_CR45","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/COC.0000000000000386","volume":"41","author":"BJ Gebhardt","year":"2018","unstructured":"Gebhardt BJ, Ohr JP, Ferris RL, Duvvuri U, Kim S, Johnson JT, et al. Concurrent chemoradiotherapy in the adjuvant treatment of high-risk primary salivary gland malignancies. Am J Clin Oncol. 2018;41(9):888\u201393.","journal-title":"Am J Clin Oncol"},{"key":"820_CR46","doi-asserted-by":"publisher","first-page":"101906","DOI":"10.1016\/j.ctrv.2019.101906","volume":"80","author":"G Lassche","year":"2019","unstructured":"Lassche G, van Boxtel W, Ligtenberg MJL, van Engen-van Grunsven ACH, van Herpen CML. Advances and challenges in precision medicine in salivary gland cancer. Cancer Treat Rev. 2019;80:101906.","journal-title":"Cancer Treat Rev"},{"key":"820_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.oraloncology.2017.02.018","volume":"68","author":"G Keller","year":"2017","unstructured":"Keller G, Steinmann D, Quaas A, Gr\u00fcnwald V, Janssen S, Hussein K. New concepts of personalized therapy in salivary gland carcinomas. Oral Oncol. 2017;68:103\u201313.","journal-title":"Oral Oncol"},{"issue":"2","key":"820_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, et al. Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019;37(2):125\u201334.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"820_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdx771","volume":"29","author":"C Fushimi","year":"2018","unstructured":"Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T, et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol. 2018;29(4):979\u201384.","journal-title":"Ann Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-021-00820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-021-00820-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-021-00820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T21:19:46Z","timestamp":1614806386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-021-00820-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s11864-021-00820-9","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"11 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nikhil P Joshi declares that he has no conflict of interest.James R Broughman declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"23"}}